{"id":"W2965274063","doi":"10.1200/jco.2006.24.18_suppl.3081","title":"A phase I study of the pan-Bcl2 family inhibitor GX15–070, administered as a 3-hour weekly infusion in patients with refractory solid tumors or lymphomas","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacokinetics; Pharmacodynamics; Adverse effect; Gastroenterology; Refractory (planetary science); Internal medicine; Pharmacology; Tolerability","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009019541,0.00159743,0.001566036,0.0004511902,0.0003934341,0.0007594115,0.0007992678,0.0009244908,0.002451024],"category_scores_gemma":[0.0005231413,0.0005463902,0.0008057019,0.0003660708,0.001037385,0.0007375358,0.0002915671,0.002434465,0.0008010165],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000744524,"about_ca_system_score_gemma":0.001165255,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009063187,"about_ca_topic_score_gemma":0.001581871,"domain_scores_codex":[0.9997335,0.0001146478,0.00001042104,0.00004617395,0.00002662775,0.00006868583],"domain_scores_gemma":[0.9996011,0.00006419827,0.00005627288,0.00004424734,0.00002250371,0.0002117197],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4610859,0.148673,0.01105612,0.001052338,0.001180165,0.0009052257,0.000964964,0.006116509,0.2112038,0.0005489895,0.004558609,0.1526544],"study_design_scores_gemma":[0.251496,0.7283604,0.01011014,0.00002147529,0.0002182077,0.0004148032,0.00007835424,0.001490427,0.005854613,0.0001420303,0.001789817,0.00002380814],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970466,0.000531946,0.0003588236,0.0001366021,0.00004431791,0.001018989,0.0002137833,0.00006072584,0.0005881587],"genre_scores_gemma":[0.9941836,0.0008899122,0.001081233,0.0003571053,0.00009059674,0.001252855,0.0009222954,0.0000207911,0.001201658],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002451024,"threshold_uncertainty_score":0.008199513,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0772347158560779,"score_gpt":0.4553294360288609,"score_spread":0.3780947201727831,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}